The proposed reforms for managed investment schemes (MIS), outlined in a consultation paper released by the government on Tuesday, include increasing ASIC’s data collection powers on the retail ...
U.S. Bank has launched the Business Shield™ Visa® card that aims to help small business owners manage their cash flow. The card offers a 0% APR on purchases and balance transfers for up to 18 months, ...
The Aussie favourite – pending Cricket Australia approval – is keen to play an additional three red-ball matches for Victoria to end the Sheffield Shield season. Boland lined up in three Shield ...
WASHINGTON, DC—This week, NASA’s new administrator, Jared Isaacman, said he has “full confidence” in the space agency’s plans to use the existing heat shield to protect the Orion spacecraft during its ...
BRAMPTON - MDA Space Ltd. has signed a deal with the U.S. Missile Defense Agency for the Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program. The company has received an ...
Democrats and ‘make America healthy again’ movement pushed back on the rider in a funding bill led by Bayer In a setback for the pesticide industry, Democrats have succeeded in removing a rider from a ...
Jan. 5 (Asia Today) --South Korea's Hanmi Semiconductor said Sunday it has launched its next-generation EMI Shield 2.0 X series, aiming to expand its footprint in the aerospace and low-Earth orbit ...
What if you could turn a simple sketch on a napkin into a fully functional web design in less than a minute? Below, Teacher’s Tech takes you through how Google Stitch 2.0, powered by the innovative ...
Taiwanese leader William Lai Ching-te wants the island to build a “T-Dome” missile shield – modelled after Israel’s Iron Dome. But his proposal has sparked debate over feasibility, given Taiwan’s ...
Investing.com - Guardant Health (NASDAQ:GH) shares declined after Raymond James maintained its Outperform rating and $61.00 price target despite the company’s Shield V2 algorithm update showing less ...
Latest algorithm (Shield V2) has sensitivity of 84% for colorectal cancer with specificity of 90%, with stage I sensitivity of 62% Performance of the Shield algorithm was validated in expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results